Pyzchiva Injection, Solution
Product Images NDC 83457-651

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 26 technical images submitted to the FDA as part of the official labeling for Pyzchiva (NDC 83457-651). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cordavis Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image Description (130 Carton)

Image Description (130 Carton)
Packaging label for Pyzchiva (ustekinumab-ttwe) injection, 130 mg/26 mL (5 mg/mL), designed for intravenous infusion only. The label includes manufacturer details (Samsung Bioepis Co., Ltd., Korea), storage instructions, dilution requirements, and a barcode. It is labeled as a single-dose vial with no preservatives and is distributed by Cordavis Limited.*
FDA Label Image

45mg-carton (45 Carton Vial)

45mg-carton (45 Carton Vial)
Packaging label for Pyzchiva (ustekinumab-ttwe) injection, 45 mg/0.5 mL, a subcutaneous human prescription drug. The label includes dosage and storage instructions, manufacturer information (Cordavis Limited, Dublin, Ireland; Samsung Bioepis Co., Ltd., Korea), and barcode. The package contains a single-dose vial and specifies no preservatives and refrigerated storage requirements.*
FDA Label Image

45-carton (45 Carton)

45-carton (45 Carton)
Carton label for Pyzchiva 45 mg/0.5 mL injection, solution for subcutaneous use. The label indicates the product is a single-dose prefilled syringe containing ustekinumab-ttwe. It includes storage instructions, manufacturer information (Cordavis Limited and Samsung Bioepis Co., Ltd.), and a barcode. The label also features images of the syringe and the Cordavis logo.*
FDA Label Image

90mg-carton (90 Carton)

90mg-carton (90 Carton)
PYZCHIVA 90 mg/mL injection, solution for subcutaneous use, presented on a carton label. The label shows a single-dose prefilled syringe containing 90 mg/mL of ustekinumab-ttwe. It includes storage instructions and manufacturer details: Cordavis Limited, Dublin, Ireland, and Samsung Bioepis Co., Ltd., Republic of Korea.*
FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
An anatomical illustration showing the labeled parts of a Pyzchiva injection syringe. Labels indicate the needle cover, needle, viewing window, body, label, needle guard wings, plunger, and plunger head components of the subcutaneous injection device.*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
An instructional illustration showing a close-up of hands manipulating a medical injection device, likely demonstrating the preparation or activation step for administering a subcutaneous injection. The device appears to be a prefilled syringe or autoinjector component, consistent with the PYZCHIVA ustekinumab-ttwe injection product.*
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
An instructional illustration showing a hand pulling off a protective cap from a prefilled injection syringe. This image likely demonstrates preparation steps for a subcutaneous injection of the drug PYZCHIVA (ustekinumab-ttwe).*
FDA Label Image

Figure-a-vial (Figure A Vial)

Figure-a-vial (Figure A Vial)
An instructional illustration showing components for administering PYZCHIVA (ustekinumab-ttwe) injection solution, including an adhesive bandage, antiseptic wipes, cotton ball or gauze pad, a vial of PYZCHIVA, a syringe with attached needle, and an FDA-cleared sharps disposal container.*
FDA Label Image

Figure-a (Figure A)

Figure-a (Figure A)
Illustration depicting the contents of a PYZCHIVA prefilled syringe medication kit. It includes a labeled prefilled syringe, an adhesive bandage, antiseptic wipes, cotton balls or gauze pads, and an FDA-cleared sharps disposal container, representing components used for subcutaneous injection of ustekinumab-ttwe.*
FDA Label Image

Figure-b-vial (Figure B Vial)

Figure-b-vial (Figure B Vial)
An instructional diagram showing recommended subcutaneous injection sites on the human body for PYZCHIVA (ustekinumab-ttwe) injection solution. Sites highlighted include the outer area of the upper arm, the abdomen around the navel excluding a 2-inch area directly around it, and the areas on the front of the thighs as well as the upper buttocks.*
FDA Label Image

Figure-b (Figure B)

Figure-b (Figure B)
An illustration of a PYZCHIVA prefilled syringe for subcutaneous injection, showing labeled parts including needle cover, needle, viewing window, product label, syringe body, needle guard wings, plunger, and plunger head. The label surface displays lot and expiration information.*
FDA Label Image

Figure-c-vial (Figure C Vial)

Figure-c-vial (Figure C Vial)
An illustration showing a vial and a partially removed or lifted flip-top cap, indicating the vial's opening mechanism. The vial is intended for a solution injection, consistent with subcutaneous administration.*
FDA Label Image

Figure-c (Figure C)

Figure-c (Figure C)
An instructional diagram showing recommended subcutaneous injection sites on the human body. The sites illustrated include the thigh, abdomen (excluding a 2-inch circle around the navel), upper arms, and buttocks.*
FDA Label Image

Figure-d-vial (Figure D Vial)

Figure-d-vial (Figure D Vial)
An instructional line drawing showing a pair of hands holding a vial while removing or twisting off the vial's cap. The image demonstrates how to open the vial for a subcutaneous injection.*
FDA Label Image

Figure-d (Figure D)

Figure-d (Figure D)
An instructional illustration showing two hands; one holding a removable cap and the other holding a syringe with a prefilled injection solution. Two arrows indicate pulling the cap off the syringe, demonstrating how to prepare the injection before use.*
FDA Label Image

Figure-e-vial (Figure E Vial)

Figure-e-vial (Figure E Vial)
An instructional illustration shows two hands preparing a syringe for injection. One hand removes the cap from the needle by pulling it off, indicated by a double-headed arrow between the hands.*
FDA Label Image

Figure-e (Figure E)

Figure-e (Figure E)
An instructional line drawing showing a hand holding and preparing to use a syringe or injection device. The image depicts the proper grip on the device for administering a subcutaneous injection, consistent with the usage of PYZCHIVA injection, solution.*
FDA Label Image

Figure-f-vial (Figure F Vial)

Figure-f-vial (Figure F Vial)
Illustration showing two hands preparing an injection by drawing solution from a vial into a syringe, demonstrating part of the subcutaneous injection process typical for drugs like PYZCHIVA (ustekinumab-ttwe).*
FDA Label Image

Figure-f (Figure F)

Figure-f (Figure F)
An instructional illustration showing a person administering a subcutaneous injection with a syringe at a 45-degree angle into the upper arm. The hands position the syringe and pinch the skin to facilitate the injection.*
FDA Label Image

Figure-g-vial (Figure G Vial)

Figure-g-vial (Figure G Vial)
An instructional line drawing showing two hands preparing a subcutaneous injection. One hand holds a vial, while the other hand is attaching a syringe needle to the vial, demonstrating medication preparation for injection.*
FDA Label Image

Figure-g (Figure G)

Figure-g (Figure G)
An instructional illustration showing hands holding a device with labeled 'needle guard wings,' likely demonstrating proper handling or usage of an injection device for PYZCHIVA (ustekinumab-ttwe) injection solution.*
FDA Label Image

Figure-h-vial (Figure H Vial)

Figure-h-vial (Figure H Vial)
An illustration showing two hands preparing an injection. One hand holds a vial upside down, inserting a syringe needle into it, while the other hand steadies the syringe barrel, indicating the step of drawing medication into the syringe. The image is instructional in nature, related to subcutaneous injection preparation.*
FDA Label Image

Figure-h (Figure H)

Figure-h (Figure H)
An instructional illustration showing a hand holding a prefilled syringe with the thumb and forefinger, demonstrating the removal of a cap or protective cover by pulling it straight off in an upward direction, indicated by a black arrow.*
FDA Label Image

Figure-i-vial (Figure I Vial)

Figure-i-vial (Figure I Vial)
An instructional illustration showing a hand administering a subcutaneous injection at a 45-degree angle into the upper arm. One hand stabilizes the injection site on the arm while the other holds the syringe for the injection.*
FDA Label Image

Figure-j-vial (Figure J Vial)

Figure-j-vial (Figure J Vial)
An instructional illustration showing a hand holding a syringe at an angle, with an arrow indicating to push the plunger, depicting how to properly administer an injection, likely subcutaneously.*
FDA Label Image

Figure4 (Figure4)

Figure4 (Figure4)
A line graph titled 'PsA STUDY 1' showing the percentage of patients over a 24-week period. The x-axis represents weeks (0 to 24), and the y-axis represents the percentage of patients (0% to 60%). Three lines depict treatment groups: placebo, ustekinumab 45 mg, and ustekinumab 90 mg, illustrating patient response rates over time for each group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.